"DKMS is an international non-profit organization dedicated to the fight against blood cancer. Founded in Germany in 1991 by Dr. Peter Harf, DKMS and the organization’s over 900 employees have since relentlessly pursued the aim of giving as many patients as possible a second chance at life. With over 10 million registered donors, DKMS has succeeded in doing this more than 92,000 times to date by providing blood stem cell donations to those in need. This accomplishment has led to DKMS becoming the global leader in the facilitation of unrelated blood stem cell transplants. The organization has offices in Germany, the US, Poland, the UK, Chile, and South Africa. In India, DKMS has founded the joint venture DKMS-BMST together with the Bangalore"

During the past decade, DKMS Americas conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "DKMS Americas" #1 collaborator was "National Marrow Donor Program" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "DKMS Americas" are "Healthy" (1 trials) and "Hematologic Neoplasms" (1 trials). Many other conditions were trialed in "DKMS Americas" in a lesser frequency.

Most popular intervention types in "DKMS Americas" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Filgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "DKMS Americas" are 2 trials for "All" genders.

Currently, there are NaN active trials in "DKMS Americas". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in DKMS Americas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in DKMS Americas, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".